Case Reports on Abetalipoproteinemia
Author Information
Author(s): Zamel Rola, Khan Razi, Pollex Rebecca L, Hegele Robert A
Primary Institution: University of Western Ontario
Hypothesis
What are the long-term clinical features and treatment outcomes of patients with abetalipoproteinemia?
Conclusion
High-dose oral vitamin therapy appears to stabilize neurological complications in patients with abetalipoproteinemia.
Supporting Evidence
- Both patients were treated with high doses of fat-soluble vitamins over several decades.
- Treatment was associated with stabilization of neurological symptoms in both patients.
- Vitamin E therapy has been shown to improve neurological function in other vitamin E deficiency conditions.
Takeaway
Abetalipoproteinemia is a rare disease that affects how the body processes fats, and giving patients high doses of certain vitamins can help them feel better.
Methodology
The study presents two case reports of patients diagnosed with abetalipoproteinemia and reviews their clinical progress and treatment outcomes.
Limitations
The findings are based on only two case reports, which may not be generalizable to all patients with abetalipoproteinemia.
Participant Demographics
Two patients, one female of Northern European descent and one female of unspecified descent, both diagnosed in childhood.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website